Immunic IncNASDAQ:IMUX
- LAST PRICE1.2600
- TODAY'S CHANGE (%)0.0300 (2.4390%)
- Bid / Lots1.2500/ 17
- Ask / Lots1.2600/ 3
- Open / Previous Close1.2400 / 1.2300
- Day Range
- 52 Week Range
- Volume167,256
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | IMUX |
|---|---|---|
| 09:32 ET | 1108 | 1.24 |
| 09:34 ET | 1500 | 1.24 |
| 09:39 ET | 510 | 1.235 |
| 09:43 ET | 100 | 1.23 |
| 09:48 ET | 200 | 1.24 |
| 09:54 ET | 100 | 1.25 |
| 09:56 ET | 1400 | 1.26 |
| 09:57 ET | 100 | 1.26 |
| 09:59 ET | 1000 | 1.2582 |
| 10:01 ET | 2700 | 1.27 |
| 10:03 ET | 2401 | 1.2631 |
| 10:06 ET | 6697 | 1.28 |
| 10:10 ET | 1081 | 1.27 |
| 10:14 ET | 2901 | 1.2675 |
| 10:15 ET | 2644 | 1.26 |
| 10:17 ET | 1902 | 1.28 |
| 10:19 ET | 2000 | 1.266 |
| 10:26 ET | 3200 | 1.27 |
| 10:30 ET | 100 | 1.28 |
| 10:32 ET | 647 | 1.269 |
| 10:35 ET | 565 | 1.28 |
| 10:42 ET | 200 | 1.27 |
| 10:46 ET | 300 | 1.27 |
| 10:53 ET | 200 | 1.28 |
| 10:57 ET | 500 | 1.275 |
| 11:00 ET | 2353 | 1.28 |
| 11:02 ET | 500 | 1.27 |
| 11:04 ET | 699 | 1.28 |
| 11:06 ET | 200 | 1.28 |
| 11:08 ET | 406 | 1.28 |
| 11:09 ET | 2000 | 1.275 |
| 11:11 ET | 734 | 1.2814 |
| 11:13 ET | 9072 | 1.31 |
| 11:15 ET | 200 | 1.3064 |
| 11:20 ET | 2100 | 1.31 |
| 11:22 ET | 1032 | 1.31 |
| 11:24 ET | 100 | 1.31 |
| 11:26 ET | 100 | 1.31 |
| 11:31 ET | 5400 | 1.31 |
| 11:33 ET | 9502 | 1.29 |
| 11:36 ET | 300 | 1.31 |
| 11:38 ET | 587 | 1.3 |
| 11:40 ET | 100 | 1.31 |
| 11:42 ET | 2245 | 1.3 |
| 11:45 ET | 3340 | 1.31 |
| 11:47 ET | 100 | 1.3 |
| 11:51 ET | 10419 | 1.2998 |
| 11:54 ET | 100 | 1.3 |
| 11:56 ET | 2889 | 1.29 |
| 11:58 ET | 1600 | 1.3 |
| 12:00 ET | 200 | 1.3 |
| 12:03 ET | 100 | 1.3 |
| 12:07 ET | 200 | 1.3 |
| 12:20 ET | 1200 | 1.2998 |
| 12:21 ET | 1000 | 1.3 |
| 12:23 ET | 2300 | 1.27 |
| 12:27 ET | 100 | 1.275 |
| 12:30 ET | 100 | 1.275 |
| 12:34 ET | 249 | 1.275 |
| 12:36 ET | 100 | 1.275 |
| 12:38 ET | 200 | 1.275 |
| 12:39 ET | 700 | 1.27 |
| 12:45 ET | 672 | 1.27 |
| 12:50 ET | 1450 | 1.26 |
| 12:56 ET | 100 | 1.28 |
| 12:57 ET | 2500 | 1.26 |
| 12:59 ET | 100 | 1.265 |
| 01:01 ET | 234 | 1.2695 |
| 01:06 ET | 800 | 1.26 |
| 01:08 ET | 332 | 1.26 |
| 01:12 ET | 100 | 1.26 |
| 01:14 ET | 100 | 1.26 |
| 01:15 ET | 200 | 1.26 |
| 01:17 ET | 2498 | 1.26 |
| 01:21 ET | 100 | 1.26 |
| 01:24 ET | 100 | 1.26 |
| 01:28 ET | 300 | 1.26 |
| 01:35 ET | 200 | 1.26 |
| 01:39 ET | 1224 | 1.25 |
| 01:42 ET | 1400 | 1.2597 |
| 01:51 ET | 1598 | 1.26 |
| 01:53 ET | 200 | 1.26 |
| 01:57 ET | 1889 | 1.255 |
| 02:00 ET | 320 | 1.2588 |
| 02:02 ET | 16457 | 1.255 |
| 02:06 ET | 700 | 1.255 |
| 02:08 ET | 100 | 1.25 |
| 02:09 ET | 5983 | 1.25 |
| 02:11 ET | 100 | 1.255 |
| 02:13 ET | 100 | 1.255 |
| 02:15 ET | 100 | 1.255 |
| 02:24 ET | 1400 | 1.25 |
| 02:26 ET | 100 | 1.255 |
| 02:27 ET | 2100 | 1.26 |
| 02:31 ET | 100 | 1.255 |
| 02:36 ET | 2090 | 1.26 |
| 02:38 ET | 572 | 1.2505 |
| 02:40 ET | 100 | 1.26 |
| 02:42 ET | 100 | 1.26 |
| 02:44 ET | 915 | 1.26 |
| 02:45 ET | 300 | 1.26 |
| 02:47 ET | 100 | 1.26 |
| 02:49 ET | 100 | 1.26 |
| 02:51 ET | 100 | 1.26 |
| 02:54 ET | 100 | 1.26 |
| 02:56 ET | 1215 | 1.26 |
| 02:58 ET | 100 | 1.26 |
| 03:00 ET | 2700 | 1.26 |
| 03:02 ET | 4172 | 1.255 |
| 03:03 ET | 100 | 1.255 |
| 03:07 ET | 100 | 1.26 |
| 03:09 ET | 300 | 1.255 |
| 03:14 ET | 100 | 1.26 |
| 03:16 ET | 2200 | 1.26 |
Apr 5, 2024
DJ Immunic Initiated at Buy by Brookline Capital, from 5:09AM ET on Friday Apr 05, 2024 by Dow Jones
5:09AM ET on Friday Apr 05, 2024 by Dow Jones
Apr 4, 2024
Immunic to Host MS R&D Day and Participate in Investor Conferences in April, from 6:30AM ET on Thursday Apr 04, 2024 by Dow Jones
6:30AM ET on Thursday Apr 04, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Immunic Inc | 110.6M | -0.6x | --- |
PDS Biotechnology Corp | 109.7M | -2.3x | --- |
Eliem Therapeutics Inc | 108.5M | -3.0x | --- |
aTyr Pharma Inc | 111.4M | -1.7x | --- |
X T L Biopharmaceuticals Ltd | 115.3M | -5.1x | --- |
GlycoMimetics Inc | 116.0M | -3.1x | --- |
Company Information
Immunic, Inc. is a biotechnology company. The Company is focused on developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases. The Company’s s lead development program, vidofludimus calcium (IMU-838), is in phase III and phase II clinical trials for the treatment of relapsing and progressive multiple sclerosis, respectively, and has shown therapeutic activity in phase II clinical trials in patients suffering from relapsing-remitting multiple sclerosis, progressive multiple sclerosis, and moderate-to-severe ulcerative colitis. IMU-856, which targets the protein Sirtuin 6 (SIRT6), is intended to restore intestinal barrier function and regenerate bowel epithelium, which could potentially be applicable in numerous gastrointestinal diseases, such as celiac disease. IMU-381 is in preclinical testing, a next generation molecule being developed to specifically address the needs of gastrointestinal diseases.
Contact Information
- Headquarters
- 1200 Avenue Of The Americas, Suite 200NEW YORK, NY, United States 10036
- Phone
- ---
- Fax
- 302-655-5049
Executives
- Executive Chairman of the Board
- Duane Nash
- President, Chief Executive Officer, Director
- Daniel Vitt
- Chief Financial Officer
- Glenn Whaley
- Chief Scientific Officer
- Hella Kohlhof
- General Counsel
- Inderpal Singh
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $110.6M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 89.9M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.93 |
EPS | $-2.11 |
Book Value | $0.64 |
P/E Ratio | -0.6x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
